Literature DB >> 33546623

Infection pattern, case fatality rate and spread of Lassa virus in Nigeria.

Clement Ameh Yaro1,2, Ezekiel Kogi3, Kenneth Nnamdi Opara4, Gaber El-Saber Batiha5, Roua S Baty6, Ashraf Albrakati7, Farag M A Altalbawy8, Innocent Utenwojo Etuh9, James Paul Oni9.   

Abstract

BACKGROUND: Lassa fever (LF) is a zoonotic infectious disease of public concern in Nigeria. The infection dynamics of the disease is not well elucidated in Nigeria. This study was carried out to describe the pattern of infection, case fatality rate and spread of lassa virus (LASV) from 2017 to 2020.
METHODS: Weekly epidemiological data on LF from December, 2016 to September, 2020 were obtained from Nigeria Centre for Disease Control. The number of confirmed cases and deaths were computed according to months and states. Descriptive statistics was performed and case fatality rate was calculated. Distribution and spread maps of LF over the four years period was performed on ArcMap 10.7.
RESULTS: A total of 2787 confirmed cases and 516 deaths were reported in Nigeria from December, 2016 to September, 2020. Increase in number of cases and deaths were observed with 298, 528, 796 and 1165 confirmed cases and 79, 125, 158 and 158 deaths in 2017, 2018, 2019 and 2020 respectively. Over 60% of the cases were reported in two states, Edo and Ondo states. The LF cases spread from 19 states in 2017 to 32 states and Federal Capital Territory (FCT) in 2020. Ondo state (25.39%) had the highest of deaths rate from LF over the four years. Case fatality rate (CFR) of LF was highest in 2017 (26.5%) with CFR of 23.7, 19.6 and 13.4% in 2018, 2019 and 2020 respectively. The peak of infection was in the month of February for the four years. Infections increases at the onset of dry season in November and decline till April when the wet season sets-in.
CONCLUSION: There is an annual increase in the number of LASV infection across the states in Nigeria. There is need to heighten control strategies through the use of integrated approach, ranging from vector control, health education and early diagnosis.

Entities:  

Keywords:  Case fatality; Infection pattern; Lassa fever; Lassa virus; Nigeria

Year:  2021        PMID: 33546623     DOI: 10.1186/s12879-021-05837-x

Source DB:  PubMed          Journal:  BMC Infect Dis        ISSN: 1471-2334            Impact factor:   3.090


  2 in total

Review 1.  Lassa fever in West African sub-region: an overview.

Authors:  O Ogbu; E Ajuluchukwu; C J Uneke
Journal:  J Vector Borne Dis       Date:  2007-03       Impact factor: 1.688

2.  A fatal case of Lassa fever in London, January 2009.

Authors:  A Kitching; S Addiman; S Cathcart; L Bischop; D Krahé; M Nicholas; J Coakley; G Lloyd; T Brooks; D Morgan; D Turbitt
Journal:  Euro Surveill       Date:  2009-02-12
  2 in total
  9 in total

1.  Temporal analysis of Lassa virus infection and transmission in experimentally infected Mastomys natalensis.

Authors:  David Safronetz; Kyle Rosenke; Kimberley Meade-White; Angela Sloan; Ousmane Maiga; Sidy Bane; Cynthia Martellaro; Dana P Scott; Nafomon Sogoba; Heinz Feldmann
Journal:  PNAS Nexus       Date:  2022-07-13

2.  Beyond Lassa Fever: Systemic and structural barriers to disease detection and response in Sierra Leone.

Authors:  Hana Rohan
Journal:  PLoS Negl Trop Dis       Date:  2022-05-19

Review 3.  The deuce-ace of Lassa Fever, Ebola virus disease and COVID-19 simultaneous infections and epidemics in West Africa: clinical and public health implications.

Authors:  Nnabueze Darlington Nnaji; Helen Onyeaka; Rine Christopher Reuben; Olivier Uwishema; Chinasa Valerie Olovo; Amarachukwu Anyogu
Journal:  Trop Med Health       Date:  2021-12-30

Review 4.  Epidemiological trends of Lassa fever in Nigeria from 2015-2021: A review.

Authors:  John-Ugwuanya A Grace; Ifunanya J Egoh; Nnenna Udensi
Journal:  Ther Adv Infect Dis       Date:  2021-11-29

Review 5.  Lassa virus glycoprotein complex review: insights into its unique fusion machinery.

Authors:  Hallie N Pennington; Jinwoo Lee
Journal:  Biosci Rep       Date:  2022-02-25       Impact factor: 3.840

Review 6.  Pathogenicity and virulence mechanisms of Lassa virus and its animal modeling, diagnostic, prophylactic, and therapeutic developments.

Authors:  Hannah L Murphy; Hinh Ly
Journal:  Virulence       Date:  2021-12       Impact factor: 5.882

7.  Knowledge of Lassa fever, its prevention and control practices and their predictors among healthcare workers during an outbreak in Northern Nigeria: A multi-centre cross-sectional assessment.

Authors:  Yusuf Hassan Wada; Ibrahim Abayomi Ogunyinka; Kazeem Babatunde Yusuff; Chinwe Lucia Ochu; Mohammed Yahaya; Garba Mohammed Khalid; Yahkub Babatunde Mutalub; Sulaiman Badmus Adeniye
Journal:  PLoS Negl Trop Dis       Date:  2022-03-14

8.  Increased Prevalence of Lassa Fever Virus-Positive Rodents and Diversity of Infected Species Found during Human Lassa Fever Epidemics in Nigeria.

Authors:  Anise N Happi; Testimony J Olumade; Olusola A Ogunsanya; Ayotunde E Sijuwola; Seto C Ogunleye; Judith U Oguzie; Cecilia Nwofoke; Chinedu A Ugwu; Samuel J Okoro; Patricia I Otuh; Louis N Ngele; Oluwafemi O Ojo; Ademola Adelabu; Roseline F Adeleye; Nicholas E Oyejide; Clinton S Njaka; Jonathan L Heeney; Christian T Happi
Journal:  Microbiol Spectr       Date:  2022-08-01

Review 9.  Lassa Fever Virus Binds Matriglycan-A Polymer of Alternating Xylose and Glucuronate-On α-Dystroglycan.

Authors:  Soumya Joseph; Kevin P Campbell
Journal:  Viruses       Date:  2021-08-25       Impact factor: 5.048

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.